|
Market Closed -
NYSE
01:00:00 21/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.900 USD | -5.23% |
|
-4.92% | +61.11% |
| 11-10 | Protalix BioTherapeutics, Inc. Reaffirms Earnings Guidance for the Full Year 2026 | CI |
| 11-10 | Protalix BioTherapeutics, Inc., Q3 2026 Earnings Call, Nov 10, 2026 |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Other Pharmaceuticals | -5.23% | -4.92% | +61.11% | +66.67% | +195.92% | 245M |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
















